Total number of projects: 5
As coordinator: 2
As participant: 2
Sole participant: 1
Coordinator / Participant Ratio: 1*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2014 | 231.283 | 0 | 231.283 | 1 | ||
2013 | 200.000 | 3.313.022 | 387.879 | 2 | 1 | |
2010 | 0 | 10.499.999 | 90.716 | 1 |
Total number of partners: 106
Partner loyalty:
Frequent Partner: (> 2 projects): 9
Rare Partner: 97
Frequent / Rare Partner Ratio: 0.09
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2014-04-04 | CHD1 Deletion: Implications to Outcome and Treatment in Prostate Cancer | CDELP | coordinator | 231.283 | 1 |
2013-10-01 | Transcribed-Ultraconserved Regions as novel biomarkers and therapeutic targets in liver cancer | LIVERNCODE | coordinator | 100.000 | 2 |
2013-06-01 | Targeting microRNAs for ColoRectal Cancer Therapy | TAMIRCRT | coordinator | 100.000 | 2 |
2013-03-01 | Decision-making within cells and differentiation entity therapies | DECIDE | participant | 3.313.022 | 8 |
2010-07-01 | Breast Cancer Somatic Genetics Study | BASIS | participant | 10.499.999 | 15 |